Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study

por Fleishaker, Dona L., Mukherjee, Arnab, Whaley, Fredrick S., Daniel, Shanthini, Zeiher, Bernhardt G.
Publicado 2016

Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies

por Orbai, Ana-Maria, Mease, Philip J., Helliwell, Philip S., FitzGerald, Oliver, Fleishaker, Dona L., Mundayat, Rajiv, Young, Pamela
Publicado 2022

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis rece...

por Kristensen, Lars E., Strober, Bruce, Poddubnyy, Denis, Leung, Ying-Ying, Jo, Hyejin, Kwok, Kenneth, Vranic, Ivana, Fleishaker, Dona L., Fallon, Lara, Yndestad, Arne, Gladman, Dafna D.
Publicado 2023

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled...

por Fleishaker, Dona L, Garcia Meijide, Juan A, Petrov, Andriy, Kohen, Michael David, Wang, Xin, Menon, Sujatha, Stock, Thomas C, Mebus, Charles A, Goodrich, James M, Mayer, Howard B, Zeiher, Bernhardt G
Publicado 2012